Ausgabe 1/2000
Inhalt (11 Artikel)
Foreword: Parkinson's Disease: Progress in Neurodegenerative and Clinical Research
W. Kuhn, T. Müller, P. H. Kraus, M. Gerlach
Involvement of α-synuclein in Parkinson's disease and other neurodegenerative disorders
R. Krüger, T. Müller, O. Riess
Altered redox state of platelet coenzyme Q10 in Parkinson's disease
M. E. Götz, A. Gerstner, R. Harth, A. Dirr, B. Janetzky, W. Kuhn, P. Riederer, M. Gerlach
Evidence for impaired presynaptic dopamine function in parkinsonian patients with motor fluctuations
R. de la Fuente-Fernández, P. K. Pal, F. J. G. Vingerhoets, A. Kishore, M. Schulzer, E. K. Mak, T. J. Ruth, B. J. Snow, D. B. Calne, A. J. Stoessl
Risk factors for dementia, depression and psychosis in long-standing Parkinson's disease
N. Giladi, T. A. Treves, D. Paleacu, H. Shabtai, Y. Orlov, B. Kandinov, E. S. Simon, A. D. Korczyn
The effects of the 21-aminosteroid U-74389G on spatial orientation in rats after a cerebral oligemic episode and iron-induced oxidative stress
C. Heim, W. Kolasiewicz, K.-H. Sontag
The activity of Catechol-O-Methyltransferase in parkinsonian patients with "on-off fluctuations"
D. Woitalla, R. Karwasz, Th. Müller, H. Przuntek, W. Kuhn
Short Communication
Tolcapone increases maximum concentration of levodopa
T. Müller, D. Woitalla, D. Schulz, S. Peters, W. Kuhn, H. Przuntek
Motor performance: normative data, age dependence and handedness
P. H. Kraus, H. Przuntek, A. Kegelmann, P. Klotz